NOS3 and Alzheimer disease: Beside anti-inflammatory [34,35], antiatherogenic ad vasorelaxant properties promoted by stimulation of eNOS [36,37], AD exerts direct cardioprotective effects mediated by signaling cascades involving AMPK and LKB1 [38].